Howard Hughes Medical Institute’s MetLife MET Stock Holding History

Howard Hughes Medical Institute’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-120	Closed	-$9.47K	–	314
2025 Q4	$9.47K	Hold	120	–	–	0.01%	220
2025 Q3	$9.88K	Sell	120 -5	-4%	-$393	0.01%	212
2025 Q2	$10.1K	Buy	+125	New	+$9.65K	﹤0.01%	202
2017 Q1	–	Sell	-3,103	Closed	-$149K	–	161
2016 Q4	$149K	Buy	+3,103	New	+$142K	0.03%	124
2016 Q3	–	Sell	-4,376	Closed	-$155K	–	166
2016 Q2	$155K	Buy	+4,376	New	+$171K	0.05%	124
2015 Q4	–	Sell	-18,353	Closed	-$771K	–	182
2015 Q3	$771K	Buy	18,353 +7,362	+67%	+$344K	0.14%	79
2015 Q2	$548K	Buy	+10,991	New	+$520K	0.12%	98
2014 Q3	–	Sell	-360	Closed	-$18K	–	190
2014 Q2	$18K	Sell	360 -2,536	-88%	-$119K	﹤0.01%	162
2014 Q1	$136K	Sell	2,896 -2,687	-48%	-$123K	0.02%	102
2013 Q4	$268K	Buy	5,583 +841	+18%	+$37.7K	0.04%	78
2013 Q3	$198K	Sell	4,742 -2,405	-34%	-$104K	0.03%	84
2013 Q2	$291K	Buy	+7,147	New	+$263K	0.1%	78

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Howard Hughes Medical Institute's MET Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of MetLife (MET) in Q1 2026, closing a stake of 120 shares — an estimated $9.47K sold.

Howard Hughes Medical Institute first reported a position in MET in Q2 2013 and held it in 12 quarters. The position peaked at $771K in Q3 2015. 1,384 funds tracked by Wall St. Rank hold MET as of Q1 2026.

Howard Hughes Medical Institute reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
Howard Hughes Medical Institute sold 120 MetLife shares in Q1 2026, an estimated $9.47K.
Howard Hughes Medical Institute first reported a position in MetLife in Q2 2013 and held it in 12 quarters.
Howard Hughes Medical Institute's MetLife position peaked at $771K in Q3 2015.
1,384 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.